Introduction {#s0005}
============

The ubiquitin-proteasome system (UPS) is the major nonlysosomal proteolytic pathway affecting crucial intracellular processes. UPS deregulation has been implicated in the efficiency of the immune response, ageing, inflammatory and many pathological processes ([@bb0245], [@bb0285], [@bb0290]).

UPS components possess potential to be a therapeutic target for treatment of several diseases ([@bb0035]).

Importance of proteasomes in both normal and pathological processes triggers interest for search of sequence variations in the proteasomal genes to be associated with human pathologies including cardio-vascular disorders ([@bb0005], [@bb0020], [@bb0030], [@bb0040], [@bb0180], [@bb0225]), *diabetes mellitus* ([@bb0220], [@bb0225]), autoimmune diseases ([@bb0215], [@bb0235], [@bb0295], [@bb0260]), children obesity ([@bb0140]), cancer and its outcome ([@bb0015]). However, these associations could significantly vary in different ethnic populations as it was shown for coronary artery disease ([@bb0270]).

No systematic analysis has been done until now to evaluate the proteasomal gene genetic diversity in humans on population level. It appears that genotyping of the *PSMB5* gene single nucleotide polymorphism (SNP) in four American ethnic groups ([@bb0275]) and the 14q13.2 microsatellite polymorphism in Latvian and Finland populations ([@bb0115], [@bb0220]) are the only studies directly addressed to that objective. Case/control disease association studies could provide significant information on population diversity. The rs1048990 of the *PSMA6* gene was widely genotyped during the last decade in several European and Asian populations for association with cardiovascular disorders, type 2 diabetes mellitus and other pathologies and their outcome ([Table 1](#t0005){ref-type="table"} and [@bb0270] for references). Several SNPs located within and upstream the *PSMA6* gene as well as within the *PSME1*, *PSME2* and *PSMA3* genes were genotyped in Latvians on susceptibility to different pathologies ([@bb0140], [@bb0225], [@bb0295], [@bb0260]). HapMap and PERLEGEN projects (<http://www.ncbi.nlm.nih.gov/snp/>) provide significant information on the genetic diversity of many individual loci in different ethnic populations; however this information is based on analysis of very small subject groups, more detailed studies are necessary.

In the current study five SNPs belonging to the *PSMA6* (rs2277460 and rs1048990), *PSMC6* (rs2295826 and rs2295827) and *PSMA3* (rs2348071) genes, have been genotyped on genetic diversity in Latvian (LV), Lithuanian (LT) and Taiwanese (TW) populations to evaluate extent of diversity and population differentiation. Allele specific patterns of transcription factor binding sites (TFBSs) and splicing signals were predicted *in silico* to reveal a potential of nucleotide substitutions in proteasomal genes to be important for human genome evolution and adaptation.

Materials and methods {#s0010}
=====================

Samples {#s0015}
-------

LV population was represented by 191 (117 females) patients of Riga Bikernieki Hospital, specialized in trauma medicine. Patients with only trauma diagnosis and without autoimmune and cardiovascular disorders, type 2 *diabetes mellitus* (T2DM) and obesity were included in this cohort. LT population was represented by 150 individuals (97 females) underwent prophylactic evaluation at Kaunas Family Medicine Centres and Hospital of Lithuanian University of Health Sciences and being without diagnosis or familial predisposition to congenital diseases, acute or chronic infections, oncological, autoimmune or any other chronic diseases, immunodeficiency and obesity. TW study subjects enrolled from elementary school for allergy diseases screen were represented by 1097 children (558 girls) without asthma and asthma history. Written informed consent was obtained from all the participants. LV, LT and TW studies were approved by the Central Medical Ethics Commission of the Latvian Ministry of Health, Kaunas Regional Biomedical Research Ethics Committee and Ethics Committee of Taoyuan General Hospital respectively.

DNA extraction and genotyping {#s0020}
-----------------------------

Genomic DNA was extracted from nucleated blood cells using a kit for genomic DNA extraction (Fermentas, Vilnius, Lithuania) or QIAamp DNA blood mini kit (Qiagen, Germany) and from oral swabs using QIAamp DNA Mini Kit (QIAGEN, Valencia, CA, USA) according to the manufacturer\'s protocols. Quality and quantity of DNA were determined using agarose gel electrophoresis and spectrophotometry. DNA samples were stored at − 80 °C until use.

[Table 1](#t0005){ref-type="table"} summarizes information on the polymorphic loci genotyped in our study.

Genotyping methods and primer sequences used by LV and LT teams are indicated in [Supplementary Table 1](#t0005){ref-type="table"}. In brief, basic PCR was performed using the DreamTaq polymerase (Fermentas, Vilnius, Lithuania) with following parameters: 94 °C for 5 min; then 35--40 cycles of 94 °C for 45 s, appropriate annealing temperature (55--61 °C) for 45 s, 72 °C for 45 s and a final extension at step at 72 °C for 7 min. DNA digestion by restriction enzymes was performed according to the producer\'s protocols (Fermentas, Vilnius, Lithuania). Allele specific amplification used to identify the rs2277460 alleles was followed by the *RsaI* digestion to genotype the rs1048990. The rs2295826 and rs2295827 were typed simultaneously in one *DdeI* digestion reaction. Amplified and digested products were analysed by electrophoresis in 1--3% agarose gel. TW team genotyped SNPs using high throughput, 384-microtiter plate, MassARRAY™ System, SEQUENOM according to the manufacturer\'s instructions. In brief, DNA containing the SNP site of interest was amplified, followed by the homogenous MassEXTEND™ assay in which label-free primer extension chemistry was used to generate allele-specific diagnostic products of unique molecular weight suitable to be distinguished through the application of matrix assisted laser desorption ionization time-of-flight mass spectrometry. For quality control 16 randomly chosen samples per each marker were genotyped in duplicate in different experiments in each LV, LT and TW population. The concordance of the genotyping was 100%. Genotyping data were verified by direct sequencing of the corresponding DNA fragments in both directions using the Applied Biosystems 3130xl Genetic Analyzer.

Alleles and genotype frequencies for the rs2277460 (ss24557113), rs1048990 (ss35076445), rs2295826 (ss3239727 and ss69157456), rs2295827 (ss23619651) and rs2348071 (ss3302481) were extracted from public available dbSNP (build 13) entries at NCBI (<http://www.ncbi.nlm.nih.gov/snp>) for 47, 40 and 43 unrelated participants of HapMap-CEU (NorthWestern European), HCB (Han Chinese) and JPT (Japanese) populations respectively and 5 locus genotypes were reconstructed for each individual.

Loci description and nucleotide numbering are given according to the recommended nomenclature system (<http://www.genomic.unimelb.edu.au/mdi/mutnomen/recs.html/>). The chromosome 14 GRCh37.p5 assembly (NCBI reference sequence: NC_000014.8) sequence information was used for loci description, nucleotide numbering and primer design that was done using the Primer 3.0 program.

Data analysis {#s0025}
-------------

Personalised genotyping data documentation resulted in knowledge of 5 locus genotype (5-LG: rs2277460/rs1048990/rs2295826/rs2295827/rs2348071) of each individual participant of the study. The 5-LGs, observed haplotypes, genotypes of each individual locus (single locus genotype or SLG) and alleles\' frequencies were estimated by direct gene counting and deviations from Hardy--Weinberg equilibrium (HWE) were tested by *χ*^2^ test ([@bb0195]; <http://www.oege.org/software/hwe-mr-calc.shtml>). DnaSP^21^ version 5 ([@bb0205]; <http://www.ub.es/dnasp/>) was used to reconstruct the haplotypes from un-phased genotypes, evaluates the nucleotide diversity, performs Tajima\'s D ([@bb0250]) and Fu and Li\'s *F*\* and *D*\* ([@bb0075]) tests of neutrality, and evaluates the pairwise linkage disequilibrium (LD) between the loci (*D*´ and r^2^) and pairwise population differentiation (*F*~st~). Haplotype age and phylogenetic relationships were obtained using the Reduced Median algorithm of the Phylogenetic network software Fluxus 4.611 (<http://www.fluxus-engineering.com>).

SNPs functional analysis in silico {#s0030}
----------------------------------

An eventual functional significance of nucleotide substitutions was analysed *in silico* on the sequence similarity to TFBSs using Genomatix software, MatInspector, release 7.4 online tool ([@bb0045]; [www.genomatix.de/](http://www.genomatix.de/){#ir0105}) with core and matrix similarity of 1.000 and more than 0.800 respectively. Splicing signals were predicted by Human Splicing Finder version 2.4 ([@bb0060]; <http://www.umd.be/HSF/>) with standard threshold values for branch point, donor and acceptor splice sites, enhancer, silencer, hnRNP and other splicing motifs.

Results {#s0035}
=======

SNPs\' diversity {#s0040}
----------------

Data on SNPs allele and genotype presentation in LV, LT and TW populations are presented in [Table 2](#t0010){ref-type="table"}. In general, alleles\' and genotypes\' distribution was similar between LV, LT and CEU and TW, CHB and JPT populations respectively (data for HapMap populations are not shown). However, the rs2277460 rare allele A being previously not found in Asians, was observed in Taiwanese; and the rs2295827 rare allele TT homozygotes found in all human populations studied previously, were not detected in Taiwanese at all. The rs2348071 allele G was major in both LV and LT populations similar to CEU and allele A was major allele in TW similar to HCB and JPT. The rs1048990 minor allele was observed more than twice frequently in TW than in each LV and LT (*P* \< 0.001) and significantly more frequent in LT compared to LV (*P* \< 0.05). Minor alleles at the rs2295826 and rs2295827 were significantly (*P* \< 0.05) less frequent in LV than in each of LT and TW and alleles\' and genotypes\' presentation was found to be similar between LT and TW (*P* \> 0.05). TW was found to deviate significantly (*P* \< 0.001) from HWE at the rs1048990 and rs2295827 where rare allele homozygotes appear to be underrepresented and at the rs2348071 where heterozygotes appear to be underrepresented. Slight underrepresentation of the rs2348071 heterozygotes (*P* \< 0.05) was also detected in LV.

To assess whether the observed patterns of SNPs diversity corresponded to expectations under the neutral model of evolution, the *D*~T~, *D*\* and *F*\* statistics were applied and data are presented in [Table 3](#t0015){ref-type="table"}. For LV and TW, *D*~T~ was negative for the rs2277460; in all other cases *D*~T~ was positive. At the rs2348071, *D*~T~ was slightly more than 2 in TW, however, it did not reach level of significance (*P* = 0.05). For all populations at all loci, *D*\* and *F*\* were positive and no *D*~T~, *D*\* and *F*\* values were significant.

Linkage disequilibrium {#s0045}
----------------------

Pairwise LD was estimated by DnaSP software and evaluated using D´ and r^2^ parameters ([Table 3](#t0015){ref-type="table"}). The rs2295826 and rs2295827 were found to be in complete LD (D´ = 1, r^2^ = 1) in LV and LT; linkage was slightly disrupted in TW (D´ = 0.978, r^2^ = 0.901).

Haplotype diversity {#s0050}
-------------------

Spectra and frequencies of five locus haplotypes are given in [Table 3](#t0015){ref-type="table"} for LV, LT, TW and HapMap CEU, HCB and JPT populations and listed in order of frequency decrease in LV. From 18 haplotypes inferred by DnaSP, the first 10 listed showed frequency higher than 5% in one population at least. Haplotypes Hap11--12 and Hap13--18 were inferred only for LT and TW respectively and appear to be rare (≤ 2%) in human populations over the world.

Patterns of haplotypes distribution are drastically different between Europeans and Asians. Hap1 being the most frequent haplotype in Europeans is only second in TW and JPT and third in HCB; Hap5 being minor in Europeans is the first in JPT, second in HCB and third in TW. More examples could be listed (see [Table 3](#t0015){ref-type="table"}). Pattern of diversity being similar between LV and CEU is different to some extent from LT. The most impressive difference concerns the Hap6 being minor (less than 5%) in both LV and CEU and presented in 11% of Lithuanians. Level of haplotype diversity is approximately the same in TW, HCB and JPT (0.779, 0.792, and 0.797 respectively); however minor in TW Hap3, Hap4, Hap7 and Hap13--18 were not suggested for HCB and JPT; Hap8 predicted for HCB and JPT was not inferred for TW. It is of interest that Hap10 absent in LV, CEU and HCB, was observed in LT, TW and JPT with similar frequency (3--6%).

Haplotypes\' distributions were analysed on neutrality of evolution by *D*~T~, *D*\* and *F*\* statistics ([Table 3](#t0015){ref-type="table"}). *D*~T~ slightly exceeded 2, was obtained only for TW, however statistical significance was not determined (*P* = 0.05); *D*~T~ values for other populations as well as *D*\* and *F*\* values for all populations were not statistically significant. The *PSMA6* (rs2277460/rs1048990) and *PSMC6* (rs2295826/rs2295827), two locus haplotype patterns were also tested on neutrality and no *D*~T~, *D*\* and *F*\* values were significant for all populations (data not shown).

[Fig. 1](#f0005){ref-type="fig"} illustrates proportions and phylogenetic relationships between haplotypes being most frequent (frequency more than 1%) in particular population. Hap2 having ancestor alleles at all five loci, was considered to be a common ancestor in all populations analysed. That haplotype being one of most wide-spread in modern Asians appears to be an immediate ancestor of the Hap1, Hap4, Hap5 and Hap9. Substitution A to G at the rs2348071 appears to be the most ancient among the analysed mutations. That mutation appears to happen about 8000--15,000 years ago and generated the Hap1, the predominant haplotype in modern Europeans. Major in Europeans and one of the most frequent in Asians, the Hap1 appears to be the immediate ancestor for Hap3, Hap6 and Hap7 having more recent time of origin.

Population differentiation {#s0055}
--------------------------

Patterns of population differentiation were analysed using F~ST~ statistics for SNPs\' and haplotype frequencies and results are presented in [Table 4](#t0020){ref-type="table"}. Locus-by-locus pairwise comparison between populations revealed significant differentiation between European populations. Both LV and LT were statistically different from CEU at the rs2277460 (*P* \< 0.05 and *P* \< 0.01 respectively). LT differed from both CEU and LV at the rs2295826 and rs2295827 (*P* \< 0.05) and from LV at the rs1048990 (*P* \< 0.01). No differentiation was revealed between TW, HCB and JPT. All LV, LT and CEU strongly (P \< 0.001) differed from Asians at the rs2277460, rs1048990 and rs2348071. However, at the rs2295826 and rs2295827 Asians were different only from LV and CEU; and exhibited similarities with LT. When five loci (1--5) haplotypes were taken into consideration, pairwise differentiation between Europeans and Asians was of strong significance (*P* \< 0.001) and LV was different from LT at nominal level of significance (*P* \< 0.05). Finally, we estimated population differentiation for *PSMA6* (rs2277460-rs10489990) and *PSMC6* (rs2295826-rs2295827) two locus haplotypes and obtained significantly different patterns of differentiation. The *PSMA6* haplotype differentiated all European populations from Asians (*P* \< 0.001 for all pairs) and LT from both LV and CEU (*P* \< 0.05) similar to five locus haplotype. When considering the *PSMC6* haplotype, LV and CEU were differentiated from LT (*P* \< 0.05) and all Asian populations (*P* \< 0.001); LT was undifferentiated from Asians (*P* \> 0.05).

Eventual functional significance of nucleotide substitutions {#s0060}
------------------------------------------------------------

[Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"} illustrate our findings on eventual functional significance of nucleotide substitutions evaluated as loss/generation of TFBSs and splicing signals in the *PSMA6*, *PSMC6* and *PSMA3* genes respectively.

No TFBSs and splicing signals were predicted for genomic region having the rs2277460 major and ancestral allele C. Substitution for rare allele A, potentially assists in creation of binding site to barbiturate inducible element BARBIE.01, and similarity to number of splicing signals including the hnRNP A1 motif.

Genomic region having the rs1048990 major and ancestral allele C, potentially possess similarity with number of splicing signals; no TFBSs were predicted. Nucleotide substitution to minor G allele significantly change patterns of sequence similarity to splicing signals, assists to sequence similarity with exonic splicing regulatory sequence and creates TFBSs of tumour suppressor p53 and DMRT families.

The rs2295826 major and ancestral allele A makes encompassing sequence to be similar to number of splicing signals including additional branch point, potential acceptor site, the hnRNP A1 motif and number of splicing enhancers and silencers as well as BSs to transcription factors of CREB, MYT1 and PARF families. Substitution to G allele appears to eliminate mentioned activities and makes sequence similar mostly to splicing silencers.

The rs2295827 major and ancestral allele C could generate additional branch point, but the sequence affinity to number of TFs of CART, BRNS, LHXF and HOXF families and similarity to number of splicing signals, depend on the presence of minor T allele.

In contrast to the loci described above, the rs2348071 ancestral allele A is the major allele only in Asian populations being the minor allele in Caucasians. When allele G is present, sequence manifests more similarity to number of splicing signals than in the case of allele A; in turn the allele A assists to sequence similarity with hnRNP A1 motif and creates BSs to TFs of CART, MEF2 and HBOX families.

Discussion/conclusion {#s0065}
=====================

In the current study we investigated genetic polymorphism of the *PSMA6* (rs2277460 and rs1048990), *PSMC6* (rs2295826 and rs2295827) and *PSMA3* (rs2348071) proteasomal genes in 1438 unrelated subjects from LV, LT and TW populations.

The rs2277460 polymorphism locates in the promoter of the *PSMA6* gene in distance of one and 110 nucleotides from the 5′-UTR and translation start respectively. Ancestral allele C, the major allele in human populations over the world, appears to be functionally neutral. Substitution to A generates binding sites to the BARBIE box proteins shown to be involved in signal transduction pathways during development ([@bb0010]) and modulation of innate immunity ([@bb0065]), hnRNP A1 known as alternative splicing repressor ([@bb0050]) and factor facilitating processing of specific microRNAs ([@bb0170]) as well as number of other splicing signals.

Transversion C → A appears to be rather recent mutation happed and fixed in Europeans in historical time. Alleles\' and genotypes\' frequencies observed in LV and LT are similar to reported previously for Latvia ([@bb0225], [@bb0295], [@bb0260]) and UK ([@bb0225]). Rare allele A not detected previously in Asian and African HapMap populations was identified in Taiwanese. In fact, our TW group represented by approximately 50 times more subjects than each HCB and JPT populations and potentially is more informative with respect to genetic diversity and rare allele, genotype and haplotype identification.

The rs1048990 SNP located in 8 nucleotides distance upstream the *PSMA6* initiation codon and four nucleotides upstream the Kozak consensus ([@bb0135]), potentially could interfere splicing and initiation of translation. In fact, [@bb0180] reported that the rs1048990 G allele was associated with higher expression of the *PSMA6* gene *in vitro* and *in vivo*. Recently, [@bb0270] compared levels of mRNA expression by the rs1048990 genotypes and significant trend by G allele was also found. We showed here that both C and G alleles could affect sequence functional potential. Ancestral allele C generates presumably splicing enhancer motifs; minor allele G creates an exonic splicing regulatory motif, several splicing silencers and binding sites for tumour suppressor p53 and double sex and mab-3 related transcription factor of DMRT family. Gene encoding the tumour suppressor p53 was shown to express ethnic heterogeneity and may be involved in ecological (climatic) adaptation ([@bb0240]). TFs of the DMRT family were shown to play significant roles during animal evolution contributing to the origin of novel sex-specific traits ([@bb0125]) and potentially should be involved in human adaptation.

Ancestral allele C is a major allele in all human populations over the world being significantly less frequent in Asians than in Europeans (about 70% vs 90% in HCB and CEU populations respectively). Similarly, in our study, we have observed the minor allele G approximately four and twice more frequent in TW compared to LV and LT respectively. Transversion C → G is one of the oldest mutations studied here and appears to happen approximately 8000--11,000 years ago in Asians. In Europeans this mutation appears to arise much later evolutionally or, more probably, had been introduced with human migrations already in historical time.

Multiple case/control studies conducted during the last decade to search for association between the rs1048990 SNP and human diseases provide significant information on locus variability. Firstly, different studies applied for the same ethnic groups (Latvians [@bb0225], [@bb0295], [@bb0260]), British ([@bb0040], [@bb0070], [@bb0225]), Indians ([@bb0020], [@bb0025]) and Japanese ([@bb0095], [@bb0110], [@bb0180], [@bb0255]) showed similar allele and genotype frequencies suggesting that control cohorts of case/control studies could successfully represent corresponding population. Secondly, locus variability appears to express geographical- and/or ethnos-specific dynamic. Minor G allele appears to be least of all presented in YRI (MAF of 0.017). In Europe, MAF appears to increase from North East (mean for LV from current and previous ([@bb0225], [@bb0295], [@bb0260]) studies equal to 0.107) to South West (0.133 in Ukraine ([@bb0105]), mean of 0.159 for UK ([@bb0040], [@bb0070], [@bb0180]) and 0.169 in Germany ([@bb0070])) remaining significantly rarer than in India (mean of 0.206 [@bb0020], [@bb0025]) and Saudi Arabia (0.231 [@bb0005]). Allele G showed the highest frequency in Eastern Asians where MAF varies from 0.317 in Japanese (mean from [@bb0095], [@bb0110], [@bb0255]) and 0.320 in Chinese ([@bb0160]) till 0.350 in Koreans ([@bb0095]).

In LV and LT groups of the current study and in vast majority of populations of published studies, the rs1048990 SNP was found to occur in frequencies consistent with HWE. However, genotype distribution was found to deviate significantly from HWE in our TW population, South Italian ([@bb0030]), Saudi ([@bb0005]) and one of Japanese control cohort ([@bb0110]). Three statistics applied in our study did not show significant deviation from neutral model of evolution.

The rs1048990 locus susceptibility reported for several pathologies ([Table 1](#t0005){ref-type="table"}) appears to have ethnos-specific character ([@bb0270]). We suggest that ethnos- and/or geographically-specific allele and genotype distribution at the rs1048990 is an evolutionary natural phenomenon involved originally in the mechanisms of ethnic adaptation to the definite environment and may influence general morbidity of human populations.

The rs2295826 and rs2295827 both located in the first intron of the *PSMC6* gene in 61 bp from each other, showed an r^2^ between 0.923 in Tuscans (Italy) and 1.0 (CEU) in different Caucasian ethnicities and a D′ of 1.0 in all ethnicities analysed until the current study, suggesting three AC, GT and GC the rs2295826/rs2295827 haplotypes. In both LV and LT populations, the rs2295826 and rs2295827 showed the same alleles\' and genotypes\' frequencies suggesting strong linkage between the loci and only AC and GT haplotypes\' occurrence. To our surprise, we did not observed in Taiwanese the rs2295827 rare allele TT homozygotes. This fact suggests a disruption of linkage between the rs2295826 and rs2295827 loci (D´ = 0.978; r^2^ = 0.901) and occurrence of forth rare AT haplotype in Taiwanese.

The rs2295826 A and rs2295827 C ancestral alleles were the major in all populations analysed. Alleles and genotypes distributions were similar between LV and CEU and TW and Asian HapMap populations respectively. To our surprise, minor alleles were significantly more frequent in LT than in LV and CEU.

The major allele of the rs2295826 generates an additional splice site acceptor and branch point, hnRNP A1 and several splicing enhancer and silencer motifs as well as sequence affinity to TFs of CREB, MYT1 and PARF families known to be involved, in regulation of multiple physiological processes including control of circadian clock ([@bb0165], [@bb0280]). Genetic variation occurred within coding and non-coding regions of several genes regulating circadian rhythm was shown to be ethnos specific ([@bb0055], [@bb0090]) and might represent an evolutional history of adaptation in populations of different geographic origin.

The rs2295826 minor allele G generates splicing silencers mostly. Additional branch point is predicted for sequence encompassing the rs2295827 major allele C. Sequences having the rs2295827 minor allele G can potentially bind the CART proteins responsible for bone and cartilage development ([@bb0080]), BRN5 and LHXF factors known to mediate transcriptional control of neuronal differentiation ([@bb0085], [@bb0185], [@bb0210], [@bb0265]) and HOXF family NANOG.01 factor shown to be generally involved in signal transduction pathways during development ([@bb0100]).

The rs2348071 polymorphism located in the intron 7 of the *PSMA3* gene strongly discriminates Asians having a major ancestral allele A (about 70%) and other ethnics having a major allele G (about 70%). Transition A → G appears to be one of the oldest among analysed mutations which happened in Caucasians about 15,000 years ago and was supported by positive selection in Caucasians over the world. Mutation age appears to be less in Asians and might result from both the *de novo* mutation event and gene flow from other ethnics.

Similar to the rs2348071, [@bb0275] identified several loci in the *PSMB1*, *PSMB2* and *PSMB5* proteasomal genes being observed as minor in one ethnic group and middle/common in others and suggested that clinical response to proteasomal inhibitors potentially might be allele specific (hypothesis is discussed in [@bb0275]).

The above mentioned and our findings indicate that loci greatly diverse between the populations in the allele and genotype presentation could potentially be involved in processes of evolutional and/or geographical adaptation of human populations to the environment. These should be of special interest and perspective for medical applications.

The rs2348071 ancestral allele A generates binding sites for already mentioned CART proteins and MEF2 and HBOX factors known to mediate transcriptional control of neuronal differentiation ([@bb0085], [@bb0185], [@bb0210], [@bb0265]) and generates splicing signals including the hnRNP A1 and several enhancer and silencer motifs. Sequence having G allele appears to have a big potential in respect of splicing regulation as many different splicing signals might be involved in regulation.

So, allele specific sequence functional motifs potentially could significantly affect particular gene expression, UPS functionality in general and network of different genes and proteins including those involved in ethnic specific adaptation to environment.

As it was expected, Taiwanese were significantly different from both the LV and LT population in the rs2277460, rs1048990 and the rs2348071 genetic diversity. However, at the rs2295826 and rs2295827, TW was different only from LV and exhibited similarity with LT. LT and LV populations showed different genetic diversity at the rs1048990, the *PSMC6* SNPs, the *PSMA6* rs2277460-rs10489990 haplotype and the 5-locus haplotype.

Finding of differentiation between the LT and LV populations appears not to be too unexpected. Living geographically close to each other and in big extent share a common paternal Y chromosome and maternal mitochondrial gene pools ([@bb0120], [@bb0150], [@bb0155], [@bb0190]), LV and LT population were shown to be different in particular markers\' frequency and haplogroups\' diversity. Examples include the Y chromosome M9 rare allele C and haplogroup HG2 being twice less frequent in LV and haplogroup HG1 observed twice more frequent in LV than in LT ([@bb0150]). Analysis of 270,000 SNPs genotyped in samples of DNA collected all over Europe revealed that the genetic structure of the European population correlates closely with geography and markers are grouped in a less compact way in Latvian population compared to Lithuanian population where more similarities with Central Europe were revealed ([@bb0175]). Allele and genotype presentation of the rs1048990 was found also to be more similar in LT with that observed in Central Europe. We did not perform ethno genetic study; ethnic origin of subjects was not recorded during sample collection. However evidently LV population in our case represents very mixed inhabitants of Riga, forming some "average" genotype for North-East Europe. On the contrary inhabitants of Kaunas are mostly Lithuanians, population is ethnically homogenous. Admixture of non-Baltic ethnic groups in Riga is reflected as similarity to the European population in general, ethnic peculiarities were revealed for Lithuania.

Similarities between LT population and Asians seem even more striking at the first glance. It is considered that Ural mountains and Caspian sea form a border between Asian and European populations ([@bb0145]), however numerous migrations across this border could result in genetic material transfer, as it was shown for some Y chromosome haplogroups ([@bb0200]). Moreover similar distribution of the D7S23 locus allelic frequencies was found among LT population, Bashkirs inhabiting Volga region, Komi living on the North-East border of Europe, and Buryat population from East Siberia ([@bb0130]). Invasions of Asian peoples to Baltics happened several times in history, some distinct groups of Turkic-speaking peoples still live in Lithuania. Thus, geographically close Baltic populations might have different microevolution of human genome acting on different traits and metabolic pathways including ubiquitin proteasome system.

In conclusion, we suggest that ethnic- and/or geographically-specific patterns of structural variations in proteasomal genes may reflect processes of local historical and/or geographical ethnos adaptation and reserve influence for human health and population morbidity in modern environment.

Appendix A. Supplementary data {#s0070}
==============================

Suppl. Table 1 Primers for DNA amplification and details of the genotyping technology used by Latvian and Lithuanian teams.
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Supplementary data to this article can be found online at [http://dx.doi.org/10.1016/j.mgene.2014.03.002](10.1016/j.mgene.2014.03.002){#ir0115}.

![Median joining network of *PSMA6*/*PSMC6*/*PSMA3* haplotypes. The network was generated using the Reduced Median algorithm of the Phylogenetic network software Fluxus 4.611 (<http://www.fluxus-engineering.com>). Panel A: LV --- Latvians, LT --- Lithuanians, CEU --- NorthWestern Europeans; Panel B: TW --- Taiwanese, HCB --- Han Chinese, JPT --- Japanese. Haplotypes are numbered as in [Table 3](#t0015){ref-type="table"}. Mutations at the rs2277460, rs1048990, rs2295826&rs2295827 and rs2348071 are indicated as stars of interrupted outline, grey, black and white colours respectively. Length of the branches is equal to time of generation and dissemination of progeny haplotype.](gr1){#f0005}

![Consequences of the rs2277460 (Panel A) and rs1048990 (Panel B) nucleotide substitutions on functional potential of corresponding genomic regions of the *PSMA6* gene. Promoter and exon are coloured in white, 5′-UTR is coloured in grey; sequences of coding and noncoding genes\' regions are presented by capital and small letters respectively. Positive and negative DNA strands are indicated by capital letters P and N respectively. The transcription factors family and matrix names are separated by symbol of division and given according to MatInspector, Release 7.4 online tool at [www.genomatix.de/](http://www.genomatix.de/){#ir0065}: BARB/BARBIE.01 --- barbiturate-inducible element; P53F/P53.07 --- tumour suppressor p53; DMRT/DMRT3.01 --- double sex and mab-3 related TF 3. Splicing enhancers are indicated by solid up-directed horizontal braces; splicing silencers are indicated by interrupted down-directed horizontal braces; splicing enhancer and silencers motifs are abbreviated according to Human Splicing Finder Version 2.4 at <http://www.umd.be/HSF>. Other abbreviations: ESR --- exonic splicing regulatory sequence. Asterix (\*) indicates situation when several splicing signals of the same type could occupy the sequence and overlap each other.](gr2){#f0010}

![Consequences of the rs2295826 (Panel A) and rs2295827 (Panel B) nucleotide substitutions on functional potential of corresponding genomic regions of the *PSMC6* gene. Sequence features and other marks are given as described in [Fig. 2](#f0010){ref-type="fig"}. CREB/E4BP4.01--E4BP4, bZIP domain, transcription repressor; MYT1/MYT1.02--MyT1 zinc finger TF involved in primary neurogenesis; PARF/TEF.01--thyrotrophic embryonic factor; CART/CART1.01--Cart-1 cartilage homeoprotein 1; BRN5/BRN5.04--POU class 6 homeobox 1 (POU6F1); LHXF/ISL2.01--ISL LIM homeobox 2; HOXF/NANOG.01--Homeobox TF Nanog. "Pot. Branch Point" means potential branch point.](gr3){#f0015}

![Consequences of the rs2348071 nucleotide substitutions on functional potential of corresponding genomic regions of the *PSMA3* gene. Sequence features and other marks are given as described in [Fig. 2](#f0010){ref-type="fig"}. HBOX/GSH1.01--Homeobox TF Gsh-1; Cart/PHOX2.01--Phox2a (ARIX) and Phox2b of cartilage homeoproteins family; MEF2/SL1.01--member of the RSRF related to serum response factors. Other abbreviations are the same as in [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}.](gr4){#f0020}

###### 

Polymorphism description.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Marker ID   Coordinates cytogenetic/genomic                                                                                                               Gene      Function                                                     MAF/MA count     Association findings   
  ----------- --------------------------------------------------------------------------------------------------------------------------------------------- --------- ------------------------------------------------------------ ---------------- ---------------------- ----------------------
  rs2277460   14q13.2:/14:35761573                                                                                                                          *PSMA6*   Promoter: c.-110[C]{.ul}\>A\                                 A = 0.0634/138   T2DM                   [@bb0225]
                                                                                                                                                                      (c.-109-1[C]{.ul}\>A)                                                                                

  JIA         [@bb0260], [@bb0295]                                                                                                                                                                                                                                         

  rs1048990   14q13.2/14:35761675                                                                                                                           *PSMA6*   5′-UTR: c.-8[C]{.ul}\>G                                      G = 0.195/425    T2DM                   [@bb0225], [@bb0030]

  CVD         [@bb0180], [@bb0220], [@bb0225], [@bb0255], [@bb0040], [@bb0160], [@bb0025], [@bb0005], [@bb0095], [@bb0105], [@bb0110]; [@bb9010][@bb0270]                                                                                                                  

  Cancer      [@bb0015]                                                                                                                                                                                                                                                    

  rs2295826   14q22.1/14:53174923                                                                                                                           *PSMC6*   Intron 1: c.128-104[A]{.ul}\>G                               G = 0.124/271    JIA                    [@bb0295]

  rs2295827   14q22.1/14:53174981                                                                                                                           *PSMC6*   Intron 1: c.128-46[C]{.ul}\>T                                T = 0.102/222    JIA                    [@bb0295]

  rs2348071   14q23/14: 58730626                                                                                                                            *PSMA3*   Intron 7: c.543 + 138G\>[A;]{.ul} c.522 + 138G\>[A;]{.ul}\   A = 0.369/804    JIA                    [@bb0295]
                                                                                                                                                                      c.576 + 138G\>[A]{.ul}                                                                               

  Obesity     [@bb0140]                                                                                                                                                                                                                                                    
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Ancestral allele is underlined in the motif description. MAF/MA count is given according to the 1000 genome phase 1 population project data Abbreviations: MAF --- minor allele frequency; MA --- allele minor in Caucasians; T2DM --- type 2 diabetes mellitus; CVD --- cardiovascular disorders; JIA --- juvenile idiopathic arthritis.

###### 

SNPs diversity in Latvian, Lithuanian and Taiwanese populations.

  Marker ID   Population   MAF      Genotype frequency   HWP (*χ*^2^)   Nucleotide diversity (π)   Test of neutrality                                       
  ----------- ------------ -------- -------------------- -------------- -------------------------- -------------------- ------------- ----------- --------- ---------
  rs2277460   LV           0.0654   0.8691               0.1309         --                         0.94                 0.12265       − 0.18389   0.42624   0.27631
  LT          0.0933       0.8133   0.1867               --             1.59                       0.16981              0.06301       0.43609     0.37690   
  TW          0.0073       0.9854   0.0146               --             0.06                       0.01449              − 0.66360     0.37096     0.03623   
  rs1048990   LV           0.0890   0.8272               0.1676         0.0052                     0.21                 0.16259       0.05540     0.42624   0.36631
  LT          0.1533       0.7067   0.2800               0.0133         0.92                       0.26051              0.60431       0.43609     0.57821   
  TW          0.3254       0.4211   0.5068               0.0702         26.15\*\*\*                0.43925              1.98494       0.37096     1.09877   
  rs2295826   LV           0.1047   0.8115               0.1673         0.0209                     2.16                 0.18799       0.20752     0.42624   0.42353
  LT          0.1700       0.7000   0.2600               0.0400         0.93                       0.28314              0.73936       0.43609     0.62844   
  TW          0.1545       0.7092   0.2726               0.0182         2.05                       0.26140              0.87595       0.37096     0.65397   
  rs2295827   LV           0.1047   0.8115               0.1673         0.0209                     2.16                 0.18799       0.20752     0.42624   0.42353
  LT          0.1700       0.7000   0.2600               0.0400         0.93                       0.28314              0.73936       0.43609     0.62844   
  TW          0.1468       0.7065   0.2935               --             34.45\*\*\*                0.25056              0.80841       0.37096     0.62677   
  rs2348071   LV           0.2932   0.5340               0.3456         0.1204                     5.28\*               0,41555       1.57068     0.42624   0.93621
  LT          0.2667       0.5400   0.3867               0.0733         0.02                       0.39242              1.39150       0.43609     0.87098   
  TW          0.6541       0.1859   0.3199               0.4941         94.14\*\*\*                0.45274              2.06904^nd^   0.37096     1.13251   

LV, LT and TW abbreviations are used to indicate Latvian, Lithuanian and Taiwanese populations respectively; MAF is given according to allele being minor in European populations. Statistical significance levels of probability correspond to: ^nd^ not determined (*P* = 0.05); \* *P* \< 0.05;  \*\*\* *P* \< 0.001.

###### 

Allelic composition, frequency and other characters of the 5 locus haplotypes in human populations.

  Haplotype              Populations (2n)                                                                                   
  ---------------------- ------------------ -------------- -------------- --------------- --------------- ----------------- --------
  Hap 1                  CCACG              0.5576         0.4967         0.6064          0.2388          0.1875            0.2558
  Hap 2                  CCACA              0.2068         0.1467         0.2021          0.3464          0.3000            0.2209
  Hap 3                  CCGTG              0.0681         0.0833         0.0638          0.0264                            
  Hap 4                  ACACA              0.0393         0.0267         0.0106          0.0027                            
  Hap 5                  CGACA              0.0340         0.0067         0.0745          0.1796          0.2625            0.2791
  Hap 6                  CGACG              0.0314         0.1100         0.0426          0.0706          0.0625            0.0581
  Hap 7                  ACACG              0.0262         0.0400                         0.0046                            
  Hap 8                  CGGTG              0.0236                                                        0.0625            0.0116
  Hap 9                  CCGTA              0.0131         0.0300                         0.0510          0.1250            0.1163
  Hap 10                 CGGTA                             0.0333                         0.0643                            0.0581
  Hap 11                 ACGTA                             0.0233                                                           
  Hap 12                 AGACG                             0.0033                                                           
  Hap 13                 CGGCA                                                            0.0068                            
  Hap 14                 CCGCG                                                            0.0023                            
  Hap 15                 CGGTG                                                            0.0023                            
  Hap 16                 CGATA                                                            0.0018                            
  Hap 17                 CCGCA                                                            0.0014                            
  Hap 18                 CCATG                                                            0.0009                            
  Hd                     0.638              0.710          0.586          0.779           0.792           0.797             
                                                                                                                            
  *Test of neutrality*                                                                                                      
  Tajima\'s D, D~T~      0.71472            1.35443        − 0.20222      2.00713^nd^     1.85362^\#^\*   1.91830^\#^\*     
  Fu and Li\'s *D*\*     0.93163            0.94926        − 0.01266      0.82277         0.96034         0.95389           
  Fu and Li\'s *F*\*     1.02654            1.29964        − 0.08777      1.52548^\#^\*   1.45955         1.1.48121^\#^\*   
  *LD 3--4*                                                                                                                 
  D´                     1.000              1.000          1.000          0.978           1.000           1.000             
  r^2^                   1.000\*\*\*B       1.000\*\*\*B   1.000\*\*\*B   0.901\*\*\*B    1.000\*\*\*B    1.000\*\*\*B      

The loci 1, 2, 3, 4, and 5 in haplotypes\' configurations correspond in sequence to the rs2277460, rs1048990, rs2295826, rs2295827 and rs2348071 loci respectively; Hd --- haplotype diversity; LD --- linkage disequilibrium. Statistical significance levels of probability correspond to: ^\#^\* 0.10 \> *P* \> 0.05; ^nd^ not determined: *P* = 0.05; \*\*\* *P* \< 0.001; B --- Bonferroni correction for multiple tests.

###### 

Pairwise estimates of F~st~ between human populations using individual SNP (1, 3, and 5 --- above first three diagonals and 2, 4 --- below first two diagonals), 5 SNPs (1--5 haplotype --- below third diagonal), *PSMA6* (1--2 haplotype --- above forth diagonal) and *PSMC6* (3--4 haplotype --- below forth diagonal) SNPs frequencies.

        SNP    LV              LT              TW              CEU             HCB             JPT
  ----- ------ --------------- --------------- --------------- --------------- --------------- ---------------
  LV    1      --              0.00228         0.04483\*\*\*   0.03655\*       0.06299\*       0.06299\*
  LT    2      0.01623\*\*     --              0.07169\*\*\*   0.06317\*\*     0.09030\*\*     0.09030\*\*
  TW           0.15592\*\*\*   0.07675\*\*\*   --              − 0.00592       0.00684         0.00684
  CEU          − 0.00291       − 0.00097       0.11528\*\*\*   --              0.0000          0.0000
  HCB          0.21074\*\*\*   0.12179\*\*\*   0.00162         0.16684\*\*\*   --              0.0000
  JPT          0.23151\*\*\*   0.14021\*\*\*   0.00794         0.18688\*\*\*   − 0.01141       --
  LV    3      --              0.01482\*       0.00958\*       0.00504         0.01850\*       0.01822\*
  LT    4      0.01482\*       --              − 0.00107       0.04788\*       − 0.00713       − 0.00682
  TW           0.00664\*       0.00004         --              0.03787\*       − 0.00317       − 0.00299
  CEU          0.00504         0.04788\*       0.03220\*       --              0.05595\*       0.05534\*
  HCB          0.01850\*       − 0.0071        − 0.00117       0.05595\*       --              − 0.01221
  JPT          0.01822\*       − 0.00682       − 0.00106       0.05534\*       − 0.01221       --
  LV    5      --              − 0.00122       0.22986\*\*\*   − 0.00658       0.26355\*\*\*   0.24855\*\*\*
  LT    1--5   0.00838\*       --              0.26109\*\*\*   − 0.00607       0.29571\*\*\*   0.28040\*\*\*
  TW           0.13338\*\*\*   0.11657\*\*\*   --              0.23385\*\*\*   − 0.00385       − 0.00509
  CEU          0.00107         0.02075\*\*     0.14034\*\*\*   --              0.26784\*\*\*   0.25274\*\*\*
  HCB          0.16164\*\*\*   0.13569\*\*\*   − 0.00145       0.17120\*\*\*   --              − 0.011181
  JPT          0.16205\*\*\*   0.13476\*\*\*   0.00023         0.17074\*\*\*   − 0.01184       --
  D                                                                                            
  LV    1--2   --              0.01058\*       0.13730\*\*\*   0.00843         0.19030\*\*\*   0.20896\*\*\*
  LT    3--4   0.01482\*       --              0.07570\*\*\*   0.01847\*       0.11609\*\*\*   0.13140\*\*\*
  TW           0.00813\*       − 0.00052       --              0.10967\*\*\*   0.00170         0.0792
  CEU          0.00504         0.04788\*       0.03508         --              0.16266\*\*\*   0.18235\*\*\*
  HCB          0.01850\*       − 0.00713       − 0.00218       0.05595\*       --              − 0.01141
  JPT          0.01822\*       − 0.00682       − 0.00204       0.05534\*       − 0.01221       --

\* indicates F~st~ values significantly different from zero: \* *P* \< 0.05; \*\* *P* \< 0.01; \*\*\* *P* \< 0.001.
